405 results
Tetralogy of Fallot Summary
 • Anatomy
 • Incidence
 • Pathophysiology
 • Presentation
 • Common Variants
 •
Tetralogy of Fallot Summary ... Management • Outcomes ... peds #pediatrics #treatment
ESICM LIVES 2019 session on Post Cardiac Arrest Care.
Summary and infographic by Tommaso Scquizzato (@tscquizzato): https://www.esicm.org/blog/?p=2337

Topics
Summary and infographic ... Patient outcome ... Heamodynamics #Monitoring #Outcomes
Management of adult IgA Vasculitis (Henoch-Schönlein purpura) - Treatment algorithm for the management of IgAV patients
algorithm for the ... the long-term outcome ... Treatment remains ... improved long-term outcome ... Rheumatology #Vasculitis #Algorithm
Global Alliance algorithm to improve outcomes in acne.
†With small nodules (>0.5–1 cm).
‡Consider physical removal of comedones.
§Second
Global Alliance algorithm ... to improve outcomes ... PrimaryCare #Acne #Treatment ... #Algorithm
Endoscopy in Barrett's Esophagus - Scoping Summary
- What we need to know?
   • Risk
Esophagus - Scoping Summary ... - Endoscopic Treatment ... Barretts #Esophagus #Summary ... diagnosis #management #algorithm
COPD Exacerbations - Management
 • Identify Triggers
 • Assess Severity
 • Risk for Poor Outcomes
 •
Risk for Poor Outcomes ... • Initial Treatment ... Exacerbation #Management #treatment
History of Systemic Thrombolysis for Ischemic Stroke and Benefit in Neurologic Outcomes - Salim R. Rezaie
in Neurologic Outcomes ... Thrombolytics #Evidence #Summary
COVID-19 Diagnosis and Management Summary

 • Clinical Presentation
 • Testing
 • Imaging
 • Laboratory Findings
 •
and Management Summary ... Laboratory Findings • Treatment ... diagnosis #management #treatment ... #summary #sarscov2
Acute Stroke - Diagnosis and Management Summary

- Dr. Declan O'Kane @drokane

#CVA #stroke #summary #diagnosis #management #treatment
and Management Summary ... #CVA #stroke #summary ... diagnosis #management #treatment
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... events, Improved outcomes